![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
RNS Number:8140W Celsis International PLC 23 March 2004 CELSIS INTERNATIONAL PLC Pre Close Trading Update Celsis International plc, a leading international manufacturer of rapid diagnostic systems for the world's pharmaceutical, personal care,dairy and beverage industries and a leading US supplier of cGMP analytical services for the pharmaceutical industry, announces an update on trading prior to the close of the financial year. The Group has made further progress across both divisions in the second half, building on the successes of the first half. As a result the Group is expected to report profits in line with market expectations for the year ended 31st March 2004. Jay LeCoque, Chief Executive Officer, Celsis Internationalplc commented: "We are very encouraged with the progress Celsis is making. The Product Group continues its robust customer expansion and is performing well across all market segments. Our personal care and pharmaceutical testing systems continueto be implemented around the world at a brisk pace. Our dairy business is poised to capture significant market share in all dairy-producing regions. The recent Parmalat bankruptcy filing has not materially impacted our business and due to our strict terms of payment, the Group had no significant exposure to bad debts with any of Parmalat's subsidiaries across the world. The Laboratory Group rebounded strongly in the fourth quarter, with revenues from this period being the largest of the year. We are confident that the softness experienced during mid-year has passed and we expect the Laboratory Group to grow at a faster and more profitable rate into our new fiscal year. Margins across both divisions continue to improve and the current US dollar situation has had no impact on our operations or profit performance. We are confident that we will shortly be in a position to announce further significant orders." 23 March 2004 Enquiries: Celsis International plc Tel: 01638 600 151 Jay LeCoque, Chief Executive Officer Jenny Parsons, Corporate Communications College Hill Tel: 020 7457 2020 Nicholas Nelson Corinna Dorward Notes to editors Celsis International plc Celsis International plc is a world leader in the development and supply of rapid diagnostic and monitoring systems to detect and measure microbial contamination in finished products bound for consumers. It has successfully developed tests for use in the pharmaceutical, personal care & cosmetic, dairy and beverage industries. These tests are based upon years of research in enzyme technology that employ numerous methods for the rapid detection of microbial contamination. Celsis International plc also has a leading laboratory services company servicing the pharmaceutical and cosmetic and toiletries industries, which operates primarily in the United States. For further information on Celsis International plc visit www.celsis.com. This information is provided by RNS The company news service from the London Stock Exchange END TSTILFETVDIFFIS
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions